nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—DRD2—Gilles de la Tourette syndrome	0.485	0.564	CbGaD
Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.375	0.436	CbGaD
Acepromazine—DRD1—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00592	0.0565	CbGpPWpGaD
Acepromazine—DRD1—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00575	0.0548	CbGpPWpGaD
Acepromazine—DRD1—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.00536	0.0511	CbGpPWpGaD
Acepromazine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00447	0.0426	CbGpPWpGaD
Acepromazine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00434	0.0414	CbGpPWpGaD
Acepromazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00389	0.148	CbGeAlD
Acepromazine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00298	0.0285	CbGpPWpGaD
Acepromazine—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0016	0.0153	CbGpPWpGaD
Acepromazine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00154	0.0585	CbGeAlD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00154	0.0146	CbGpPWpGaD
Acepromazine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00149	0.0142	CbGpPWpGaD
Acepromazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00142	0.0135	CbGpPWpGaD
Acepromazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00138	0.0131	CbGpPWpGaD
Acepromazine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00135	0.0516	CbGeAlD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00132	0.0126	CbGpPWpGaD
Acepromazine—DRD1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00131	0.0125	CbGpPWpGaD
Acepromazine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.0013	0.0497	CbGeAlD
Acepromazine—DRD1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0013	0.0124	CbGpPWpGaD
Acepromazine—DRD1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00127	0.0121	CbGpPWpGaD
Acepromazine—DRD1—nervous system—Gilles de la Tourette syndrome	0.00126	0.0481	CbGeAlD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00126	0.012	CbGpPWpGaD
Acepromazine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00122	0.0463	CbGeAlD
Acepromazine—DRD1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00121	0.0116	CbGpPWpGaD
Acepromazine—DRD1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00118	0.0113	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00116	0.0111	CbGpPWpGaD
Acepromazine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00114	0.0109	CbGpPWpGaD
Acepromazine—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00113	0.0107	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00112	0.0106	CbGpPWpGaD
Acepromazine—DRD1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0011	0.0105	CbGpPWpGaD
Acepromazine—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00109	0.0104	CbGpPWpGaD
Acepromazine—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00107	0.0102	CbGpPWpGaD
Acepromazine—DRD1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00107	0.0102	CbGpPWpGaD
Acepromazine—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00104	0.00992	CbGpPWpGaD
Acepromazine—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00104	0.00989	CbGpPWpGaD
Acepromazine—ADRA1B—brain—Gilles de la Tourette syndrome	0.00103	0.0395	CbGeAlD
Acepromazine—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00102	0.00971	CbGpPWpGaD
Acepromazine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.001	0.0383	CbGeAlD
Acepromazine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.000999	0.0381	CbGeAlD
Acepromazine—DRD1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000995	0.00949	CbGpPWpGaD
Acepromazine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000988	0.00942	CbGpPWpGaD
Acepromazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000983	0.00938	CbGpPWpGaD
Acepromazine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000973	0.00927	CbGpPWpGaD
Acepromazine—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00097	0.00925	CbGpPWpGaD
Acepromazine—DRD1—brain—Gilles de la Tourette syndrome	0.000965	0.0368	CbGeAlD
Acepromazine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.000962	0.0367	CbGeAlD
Acepromazine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00096	0.00915	CbGpPWpGaD
Acepromazine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000952	0.00908	CbGpPWpGaD
Acepromazine—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000946	0.00902	CbGpPWpGaD
Acepromazine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000944	0.009	CbGpPWpGaD
Acepromazine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000925	0.00882	CbGpPWpGaD
Acepromazine—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000919	0.00876	CbGpPWpGaD
Acepromazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000907	0.0346	CbGeAlD
Acepromazine—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000901	0.00859	CbGpPWpGaD
Acepromazine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00088	0.00839	CbGpPWpGaD
Acepromazine—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000875	0.00834	CbGpPWpGaD
Acepromazine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000861	0.00821	CbGpPWpGaD
Acepromazine—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000856	0.00816	CbGpPWpGaD
Acepromazine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000831	0.00792	CbGpPWpGaD
Acepromazine—DRD1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000829	0.00791	CbGpPWpGaD
Acepromazine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000825	0.0315	CbGeAlD
Acepromazine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000818	0.0078	CbGpPWpGaD
Acepromazine—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000815	0.00777	CbGpPWpGaD
Acepromazine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000807	0.00769	CbGpPWpGaD
Acepromazine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000801	0.00763	CbGpPWpGaD
Acepromazine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000794	0.0303	CbGeAlD
Acepromazine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000794	0.00757	CbGpPWpGaD
Acepromazine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000777	0.00741	CbGpPWpGaD
Acepromazine—SLC22A1—brain—Gilles de la Tourette syndrome	0.000764	0.0291	CbGeAlD
Acepromazine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000761	0.029	CbGeAlD
Acepromazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000746	0.0284	CbGeAlD
Acepromazine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000739	0.00705	CbGpPWpGaD
Acepromazine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000732	0.0279	CbGeAlD
Acepromazine—ALB—brain—Gilles de la Tourette syndrome	0.000731	0.0279	CbGeAlD
Acepromazine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000724	0.0069	CbGpPWpGaD
Acepromazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000718	0.0274	CbGeAlD
Acepromazine—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000713	0.0068	CbGpPWpGaD
Acepromazine—DRD1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000697	0.00665	CbGpPWpGaD
Acepromazine—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000679	0.00648	CbGpPWpGaD
Acepromazine—HTR1A—brain—Gilles de la Tourette syndrome	0.000631	0.0241	CbGeAlD
Acepromazine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000626	0.00597	CbGpPWpGaD
Acepromazine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000603	0.00575	CbGpPWpGaD
Acepromazine—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000599	0.00572	CbGpPWpGaD
Acepromazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000598	0.0228	CbGeAlD
Acepromazine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000581	0.0222	CbGeAlD
Acepromazine—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000571	0.00544	CbGpPWpGaD
Acepromazine—DRD2—brain—Gilles de la Tourette syndrome	0.00057	0.0217	CbGeAlD
Acepromazine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000526	0.00502	CbGpPWpGaD
Acepromazine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000507	0.00483	CbGpPWpGaD
Acepromazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000492	0.0188	CbGeAlD
Acepromazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000473	0.0181	CbGeAlD
Acepromazine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000432	0.00412	CbGpPWpGaD
Acepromazine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000419	0.004	CbGpPWpGaD
Acepromazine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000405	0.00387	CbGpPWpGaD
Acepromazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000379	0.0426	CrCbGaD
Acepromazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000376	0.0143	CbGeAlD
Acepromazine—DRD1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000309	0.00294	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000299	0.00286	CbGpPWpGaD
Acepromazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000295	0.0331	CrCbGaD
Acepromazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000288	0.0324	CrCbGaD
Acepromazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000286	0.0321	CrCbGaD
Acepromazine—DRD1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000279	0.00266	CbGpPWpGaD
Acepromazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000259	0.0291	CrCbGaD
Acepromazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000258	0.029	CrCbGaD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000253	0.00241	CbGpPWpGaD
Acepromazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000246	0.0277	CrCbGaD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000245	0.00234	CbGpPWpGaD
Acepromazine—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.000235	0.0264	CrCbGaD
Acepromazine—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000234	0.00223	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000233	0.00222	CbGpPWpGaD
Acepromazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000232	0.0261	CrCbGaD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000228	0.00218	CbGpPWpGaD
Acepromazine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000227	0.00217	CbGpPWpGaD
Acepromazine—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000227	0.00217	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000226	0.00216	CbGpPWpGaD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000217	0.00207	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000216	0.00206	CbGpPWpGaD
Acepromazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000213	0.024	CrCbGaD
Acepromazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000212	0.0239	CrCbGaD
Acepromazine—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000212	0.00202	CbGpPWpGaD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000211	0.00201	CbGpPWpGaD
Acepromazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.00021	0.0236	CrCbGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00021	0.002	CbGpPWpGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000207	0.00197	CbGpPWpGaD
Acepromazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000207	0.0232	CrCbGaD
Acepromazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000207	0.0232	CrCbGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000206	0.00196	CbGpPWpGaD
Acepromazine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000206	0.00196	CbGpPWpGaD
Acepromazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000204	0.0229	CrCbGaD
Acepromazine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000202	0.0227	CrCbGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000201	0.00192	CbGpPWpGaD
Acepromazine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0002	0.0019	CbGpPWpGaD
Acepromazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000198	0.0222	CrCbGaD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000196	0.00187	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000196	0.00187	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000191	0.00182	CbGpPWpGaD
Acepromazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000188	0.0211	CrCbGaD
Acepromazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000188	0.00179	CbGpPWpGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000187	0.00178	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000186	0.00177	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000185	0.00177	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000184	0.00176	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000184	0.00175	CbGpPWpGaD
Acepromazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000182	0.00174	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000181	0.00172	CbGpPWpGaD
Acepromazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000179	0.0201	CrCbGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000178	0.0017	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000177	0.00169	CbGpPWpGaD
Acepromazine—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000177	0.0199	CrCbGaD
Acepromazine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000174	0.00166	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000172	0.00164	CbGpPWpGaD
Acepromazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000172	0.0193	CrCbGaD
Acepromazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00017	0.00162	CbGpPWpGaD
Acepromazine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00017	0.00162	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000168	0.00161	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000166	0.00158	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000165	0.00157	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000163	0.00156	CbGpPWpGaD
Acepromazine—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.000163	0.0183	CrCbGaD
Acepromazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000162	0.0182	CrCbGaD
Acepromazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000162	0.0182	CrCbGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000161	0.00153	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00016	0.00153	CbGpPWpGaD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00016	0.00153	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00016	0.00153	CbGpPWpGaD
Acepromazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.00016	0.018	CrCbGaD
Acepromazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.00016	0.018	CrCbGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000159	0.00151	CbGpPWpGaD
Acepromazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000158	0.0177	CrCbGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000157	0.0015	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000156	0.00149	CbGpPWpGaD
Acepromazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000154	0.0173	CrCbGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000153	0.00146	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000152	0.00145	CbGpPWpGaD
Acepromazine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000151	0.00144	CbGpPWpGaD
Acepromazine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.00015	0.0169	CrCbGaD
Acepromazine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.00015	0.0169	CrCbGaD
Acepromazine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000149	0.00142	CbGpPWpGaD
Acepromazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000147	0.0165	CrCbGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000145	0.00139	CbGpPWpGaD
Acepromazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000145	0.0163	CrCbGaD
Acepromazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000143	0.0161	CrCbGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000142	0.00136	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000142	0.00135	CbGpPWpGaD
Acepromazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000141	0.0159	CrCbGaD
Acepromazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000138	0.0155	CrCbGaD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000138	0.00131	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000138	0.00131	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000137	0.00131	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000135	0.00129	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000135	0.00128	CbGpPWpGaD
Acepromazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.000133	0.0149	CrCbGaD
Acepromazine—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000132	0.0148	CrCbGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000131	0.00125	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000131	0.00125	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000128	0.00122	CbGpPWpGaD
Acepromazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000127	0.0143	CrCbGaD
Acepromazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000126	0.0142	CrCbGaD
Acepromazine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000126	0.0012	CbGpPWpGaD
Acepromazine—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.000126	0.0141	CrCbGaD
Acepromazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000124	0.00119	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000123	0.00118	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000122	0.00117	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000122	0.00116	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000121	0.00115	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000121	0.00115	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00012	0.00114	CbGpPWpGaD
Acepromazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000119	0.0134	CrCbGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000119	0.00113	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000118	0.00112	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000116	0.00111	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000116	0.00111	CbGpPWpGaD
Acepromazine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000116	0.0131	CrCbGaD
Acepromazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000114	0.0128	CrCbGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000112	0.00107	CbGpPWpGaD
Acepromazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000112	0.0126	CrCbGaD
Acepromazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000112	0.0126	CrCbGaD
Acepromazine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000112	0.0125	CrCbGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000111	0.00106	CbGpPWpGaD
Acepromazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.00011	0.0124	CrCbGaD
Acepromazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000109	0.0123	CrCbGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000108	0.00103	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000104	0.000996	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000104	0.000987	CbGpPWpGaD
Acepromazine—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000102	0.0114	CrCbGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.97e-05	0.000951	CbGpPWpGaD
Acepromazine—Promazine—HTR2A—Gilles de la Tourette syndrome	9.84e-05	0.0111	CrCbGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	9.36e-05	0.000893	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.32e-05	0.000888	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.04e-05	0.000862	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.98e-05	0.000856	CbGpPWpGaD
Acepromazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	8.66e-05	0.00973	CrCbGaD
Acepromazine—Imipramine—HTR2A—Gilles de la Tourette syndrome	8.62e-05	0.00968	CrCbGaD
Acepromazine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.55e-05	0.000815	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.46e-05	0.000807	CbGpPWpGaD
Acepromazine—ALB—Metabolism—HDC—Gilles de la Tourette syndrome	8.43e-05	0.000804	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.42e-05	0.000803	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.21e-05	0.000783	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.01e-05	0.000764	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.88e-05	0.000752	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.78e-05	0.000741	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.65e-05	0.000729	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.63e-05	0.000727	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.59e-05	0.000724	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.41e-05	0.000706	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.27e-05	0.000694	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.24e-05	0.000691	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.06e-05	0.000673	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.03e-05	0.000671	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.93e-05	0.000661	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.92e-05	0.00066	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.9e-05	0.000658	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.83e-05	0.000651	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.78e-05	0.000646	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.73e-05	0.000641	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.72e-05	0.000641	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.58e-05	0.000627	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.58e-05	0.000627	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.39e-05	0.000609	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.28e-05	0.000599	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.26e-05	0.000597	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.26e-05	0.000597	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.26e-05	0.000597	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.2e-05	0.000591	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.15e-05	0.000587	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.13e-05	0.000584	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.1e-05	0.000582	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.97e-05	0.00057	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.9e-05	0.000563	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.68e-05	0.000542	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.56e-05	0.000531	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.36e-05	0.000511	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.07e-05	0.000484	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5e-05	0.000476	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.85e-05	0.000463	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.83e-05	0.000461	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.61e-05	0.000439	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.52e-05	0.000431	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.45e-05	0.000425	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.39e-05	0.000418	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.3e-05	0.00041	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.29e-05	0.000409	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.17e-05	0.000398	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.09e-05	0.00039	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.05e-05	0.000386	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.97e-05	0.000379	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.9e-05	0.000372	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.89e-05	0.000371	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.77e-05	0.00036	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.71e-05	0.000354	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.7e-05	0.000353	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.66e-05	0.000349	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.63e-05	0.000347	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.6e-05	0.000344	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.53e-05	0.000336	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.36e-05	0.00032	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.29e-05	0.000313	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.17e-05	0.000302	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.72e-05	0.00026	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.59e-05	0.000247	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.39e-05	0.000228	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.3e-05	0.00022	CbGpPWpGaD
